Local Regional Management of Early-Stage Breast Cancer in Oncology
The locoregional management of early (non-metastatic) breast cancer has converged on a small set of evidence-based rules, reviewed here through a JCO special issue (July 10, 2020). Lumpectomy margins: for invasive cancer "no ink on tumor" is enough, since wider margins do not further lower local recurrence, while DCIS treated with whole-breast radiation needs a 2 mm margin. Accelerated partial breast irradiation (APBI), given over 5–10 days, matches whole-breast irradiation (3–6 weeks) for carefully selected patients: about 50 or older, small tumours, hormone receptor-positive, negative margins and nodes, no lymphovascular invasion. With limited nodal disease the axilla can often be treated with radiation instead of axillary dissection (AMAROS, ACOSOG Z0011), which gives similar recurrence and less lymphedema. After neoadjuvant chemotherapy a pathologic complete response predicts locoregional control, and sentinel node biopsy remains accurate. Because each case is nuanced, these reviews serve as food for thought alongside NCCN algorithms. This belongs to oncology, specifically the surgical and radiation management of early-stage breast cancer.